Tiziano Scarabelli, MD, PhD, is an Associate Professor of Medicine in the UAB Division of Cardiovascular Disease. Prior to joining UAB in August 2015, Dr. Scarabelli was an Associate Professor of Medicine at Wayne State University School of Medicine, Detroit, Michigan, and Director of the Center for Heart and Vessel Preclinical Studies, a translational research laboratory based at St. John Hospital and Medical Center, a teaching hospital affiliated with Wayne State University.

Dutton Gareth PhDBiosketch & Research Interests 

Gareth Dutton, PhD, is an Associate Professor of Medicine in the UAB Division of Preventive Medicine. Prior to joining UAB in 2011, Dr. Dutton was an Assistant Professor in the Department of Medical Humanities and Social Sciences at the Florida State University College of Medicine.  Dr. Dutton received his PhD in clinical psychology with an emphasis in behavioral medicine from Louisiana State University.  He completed his pre-doctoral clinical internship at Brown University. Dr. Dutton’s research is focused on the development and evaluation of lifestyle interventions for weight loss and weight loss maintenance. This work includes identification of variables associated with treatment response, including individual factors (e.g., self-efficacy, goal focus, demographic characteristics) and program factors (e.g., size of treatment groups, schedule of treatment contacts, modality of treatment delivery).

Singh Jasvinder MDDr. Singh is a Professor in the Division of Rheumatology and Clinical Immunology. The primary goal of Dr. Singh’s research is to improve the outcomes of patients with arthritis and rheumatic conditions. The objectives of Dr. Singh’s research program are, (1) to advance evidence-based medicine by performing state-of-the-art Cochrane Systematic Reviews, Meta-analyses and Network Meta-analyses as well as the development and dissemination of treatment guidelines that can change the way we provide the best care to patients with rheumatic conditions, and (2) to improve our understanding of what impacts poor patient outcomes, including pain and function in arthritis, and design interventions to improve these outcomes.

Brent Carter MDDr. Carter is a Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine. The primary goal of Dr. Carter's research is to understand the molecular mechanisms that modulate the development of lung injury and pulmonary fibrosis. Specifically, his laboratory focuses on the role of macrophage phenotype, macrophage-derived oxidant production, mitochondrial metabolism, and signaling in the pathogenesis of pulmonary fibrosis.

Hsh phdDr. Hui-Chen Hsu is Associate Professor of Medicine in the Division of Clinical Immunology and Rheumatology. Dr. Hsu collaborated with Drs. John D. Mountz, Hao Li, Jun Li, Yong Zhou, David Crossman, Janusz H. Kabarowski and several other leading investigators in the field and made the seminal discovery on a novel pathogenic role of type I interferon (IFN) in promoting systemic lupus erythematosus (SLE), a challenging autoimmune disease without a cure. The work stemmed from Dr. Hsu’s research which focuses on how elevated type I IFNs produced by plasmacytoid dendritic cells (pDCs) in the spleen marginal zone can induce follicular translocation of marginal zone (MZ) B cells.

Timmy Lee MDTimmy Lee, MD, MSPH, is Associate Professor of Medicine in the Division of Nephrology and Staff Nephrologist at the Birmingham Veterans Affairs Medical Center. He is the Associate Director of Interventional Nephrology, Director of Hemodialysis at the Birmingham Veterans Affairs Medical Center, and Associate Fellowship Director of UAB Nephrology Fellowship Program. He also currently serves as a Councilor for the American Society of Diagnostic and Interventional Nephrology.